Investigating the regulatory role of miRNAs as silent conductors in the management of pathogenesis and therapeutic resistance of pancreatic cancer

AI Abulsoud, SS Elshaer, NM Abdelmaksoud… - … -Research and Practice, 2023 - Elsevier
Pancreatic cancer (PC) has the greatest mortality rate of all the main malignancies. Its
advanced stage and poor prognosis place it at the bottom of all cancer sites. Hence …

m6A demethylase ALKBH5 inhibits pancreatic cancer tumorigenesis by decreasing WIF-1 RNA methylation and mediating Wnt signaling

B Tang, Y Yang, M Kang, Y Wang, Y Wang, Y Bi, S He… - Molecular cancer, 2020 - Springer
Background Pancreatic cancer is one of the most lethal types of cancer with extremely poor
diagnosis and prognosis, and chemo-resistance remains a major challenge. The dynamic …

Mitochondria determine response to anti-programmed cell death protein-1 (anti-PD-1) immunotherapy: An evidence-based hypothesis

H Akbari, F Taghizadeh-Hesary, M Bahadori - Mitochondrion, 2022 - Elsevier
Immunotherapy based on programmed cell death protein-1 (PD-1) is a promising approach
in oncology. However, a significant fraction of patients remain unresponsive. Therefore, it is …

Therapeutic approaches in pancreatic cancer: recent updates

L Kumar, S Kumar, K Sandeep, SKS Patel - Biomedicines, 2023 - mdpi.com
Cancer is a significant challenge for effective treatment due to its complex mechanism,
different progressing stages, and lack of adequate procedures for screening and …

MicroRNA-137 reduces stemness features of pancreatic cancer cells by targeting KLF12

Z He, X Guo, S Tian, C Zhu, S Chen, C Yu… - Journal of Experimental …, 2019 - Springer
Abstract Background Cancer stem cells (CSCs) play an important role in the development of
pancreatic cancer. We previously showed that the microRNA miR-137 is downregulated in …

Flavonoids Targeting the mTOR Signaling Cascades in Cancer: A Potential Crosstalk in Anti‐Breast Cancer Therapy

Y Hussain, H Khan, W Alam, M Aschner… - Oxidative Medicine …, 2022 - Wiley Online Library
Cancer is one of the leading causes of death worldwide. Breast cancer is the second
leading cause of death in women, with triple‐negative breast cancer being the most lethal …

Asymmetrically substituted quadruplex-binding naphthalene diimide showing potent activity in pancreatic cancer models

AA Ahmed, R Angell, S Oxenford… - ACS Medicinal …, 2020 - ACS Publications
Targeting of genomic quadruplexes is an approach to treating complex human cancers. We
describe a series of tetra-substituted naphthalene diimide (ND) derivatives with a phenyl …

Deciphering role of FGFR signalling pathway in pancreatic cancer

X Kang, Z Lin, M Xu, J Pan, Z Wang - Cell proliferation, 2019 - Wiley Online Library
Recently, fibroblast growth factors are identified to play a vital role in the development and
progression of human pancreatic cancer. FGF pathway is critical involved in numerous …

[HTML][HTML] Changes in cytokeratin 18 during neoadjuvant chemotherapy of breast cancer: a prospective study

D Fazilat-Panah, SVA Roudi, A Keramati… - Iranian journal of …, 2020 - ncbi.nlm.nih.gov
Methods: This research was performed on newly diagnosed breast cancer patients referred
to Omid Radiotherapy Center and radiotherapy and oncology departments of Emam Reza …

[HTML][HTML] Advances in understanding the mechanisms of evasive and innate resistance to mTOR inhibition in cancer cells

F Chiarini, C Evangelisti, G Lattanzi… - … et Biophysica Acta (BBA …, 2019 - Elsevier
The development of drug-resistance by neoplastic cells is recognized as a major cause of
targeted therapy failure and disease progression. The mechanistic (previously mammalian) …